NEWS COMMENTARY

Terramera receives $10 million from BDC to commercialize its Actigate biopesticide enhancement technology

Published:
February 21, 2019
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Investment
12744 thumb square
by Joshua Haslun
Truly disruptive

The subordinated debt financing round indicates BDC's trust in Terramera's technology to decrease the use of chemical pest control while improving yields. The financing is part of BDC's commitment to enable the growth of Canadian cleantech developers. Lux has followed Terramera (Lux Take: Positive), identifying it as key innovator in the biopesticide space. One of the major challenges facing the expanded use of biopesticides is the high cost of production and low efficacy of application. By increasing the effectiveness of biopesticides, the cost of application substantially decreases, and competition with conventional pesticides becomes a reality. Clients should look to co-development of biopesticides using Terramera's Actigate technology.

For the original news article, click here .


Further Reading

Cavallo Ventures invests in protective crop coating technology from Crop Enhancement as pesticide alternative

News Commentary | January 25, 2019

While the investment size remains undisclosed (rumored at seven digits by Forbes), the funding is well‑timed to enable the expansion of sales for the company's first product, CropCoat (expected launch in 2019), and the development of its second product, a tunable active ingredient release (AIR) ... Not part of subscription

Syngenta Ventures makes another move in biopesticides with $2.9 million seed-stage investment in BioPhero

News Commentary | October 3, 2018

Syngenta, Novo Holdings, and Syddansk Innovation participated in BioPhero's $2.9 million seed fundraising round. BioPhero is a biopesticide developer, working to make pheromones for insect control using fermentation. As pheromone production through synthetic methods is costly, slow, and inefficient... Not part of subscription

J.R. Simplot looks to a future of CRISPR potatoes

News Commentary | August 9, 2018

J.R. Simplot announced a joint nonexclusive licensing agreement with Corteva Agriscience and the Broad Institute of MIT and Harvard for use of CRISPR‑Cas9 gene editing (GE). J.R. Simplot, one of the largest producers of potatoes in the U.S., is likely to apply GE to address the $1 billion annual ... Not part of subscription